MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$1,314,352K
Cash and cash
equivalents
$382,517K
Prepaid and other
current assets
$101,598K
Total current assets
$1,798,467K
Other assets
$82,175K
Right-of-use assets
$51,278K
Property and equipment,
net
$23,333K
Restricted cash
$2,797K
Total assets
$1,958,050K
Total liabilities and
stockholders equity
$1,958,050K
Total stockholders
equity
$1,688,600K
Total liabilities
$269,450K
Accumulated deficit
-$1,577,697K
Additional paid-in capital
$3,263,720K
Total current
liabilities
$195,446K
Lease liabilities,
net of current...
$45,313K
Deferred revenue, net of
current portion
$28,691K
Accumulated other
comprehensive income
$2,562K
Common stock, 0.0001
par value...
$15K
Accrued expenses and
other liabilities
$157,466K
Deferred revenue,
current portion
$21,639K
Accrued manufacturing
and technical...
$12,403K
Lease liabilities,
current portion
$3,938K
Back
Back
Balance Sheet
source: myfinsight.com
Avidity Biosciences, Inc. (RNA)
Avidity Biosciences, Inc. (RNA)